rs1049346
From SNPedia
Orientation | minus |
Stabilized | minus |
Make rs1049346(C;C) |
Make rs1049346(C;T) |
Make rs1049346(T;T) |
Reference | GRCh38.p2 38.2/144 |
Chromosome | 6 |
Position | 38703061 |
Gene | GLO1 |
is a | snp |
is | mentioned by |
dbSNP | rs1049346 |
dbSNP (classic) | rs1049346 |
ClinGen | rs1049346 |
ebi | rs1049346 |
HLI | rs1049346 |
Exac | rs1049346 |
Gnomad | rs1049346 |
Varsome | rs1049346 |
LitVar | rs1049346 |
Map | rs1049346 |
PheGenI | rs1049346 |
Biobank | rs1049346 |
1000 genomes | rs1049346 |
hgdp | rs1049346 |
ensembl | rs1049346 |
geneview | rs1049346 |
scholar | rs1049346 |
rs1049346 | |
pharmgkb | rs1049346 |
gwascentral | rs1049346 |
openSNP | rs1049346 |
23andMe | rs1049346 |
SNPshot | rs1049346 |
SNPdbe | rs1049346 |
MSV3d | rs1049346 |
GWAS Ctlg | rs1049346 |
Max Magnitude | 0 |
? | (C;C) (C;T) (T;T) | 28 |
---|---|---|
|
[PMID 25201284] The GLO1 C332 (Ala111) allele confers autism vulnerability: family-based genetic association and functional correlates
[PMID 27000251] Role of glyoxalase I gene polymorphisms in late-onset epilepsy and drug-resistant epilepsy The CC genotype of rs1049346 protects against late-onset epilepsy and drug resistant epilepsy.
The presence of the TAC/AAT haplotypes (rs1130534-rs4746-rs1049346) may be used as a marker of predisposition to/protection against
drug resistant epilepsy. rs1049346 is not on the typically used gene chips, though there is a perfect proxy, Rs1781735, on the 23andme v3 chip.
Risk by genotype will be posted to the rs1781735 page.